tiprankstipranks
BB Biotech AG (DE:BBZA)
XETRA:BBZA
Germany Market
BBZA
BB Biotech
RESEARCH TOOLSreports

BB Biotech (BBZA) Ratios

14 Followers

BB Biotech Ratios

DE:BBZA's free cash flow for Q2 2026 was CHF1.00. For the 2026 fiscal year, DE:BBZA's free cash flow was decreased by CHF and operating cash flow was CHF4.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.00 0.00 19.88 158.32 <0.01
Quick Ratio
 0.00 0.00 19.88 158.32 <0.01
Cash Ratio
 0.00 0.00 <0.01 0.03 <0.01
Solvency Ratio
 254.98 82.90 0.63 -1.19 -1.83
Operating Cash Flow Ratio
 0.00 0.00 2.51 13.10 -0.97
Short-Term Operating Cash Flow Coverage
 0.00 0.00 2.59 0.72 -0.99
Net Current Asset Value
CHF 3.08BCHF 97.95MCHF 2.29BCHF 2.32BCHF -365.31M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.05 0.12 0.12
Debt-to-Equity Ratio
 0.00 0.00 0.05 0.13 0.14
Debt-to-Capital Ratio
 0.00 0.00 0.05 0.12 0.12
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.12
Financial Leverage Ratio
 1.00 1.00 1.05 1.14 1.14
Debt Service Coverage Ratio
 0.00 1.31K 0.66 -0.65 -0.98
Interest Coverage Ratio
 0.00 1.32K 16.95 -5.16 -22.38
Debt to Market Cap
 0.00 0.00 0.06 0.13 0.24
Interest Debt Per Share
 0.00 <0.01 2.23 5.67 6.63
Net Debt to EBITDA
 -0.15 -0.17 1.46 -1.51 -1.01
Profitability Margins
Gross Profit Margin
100.00%99.93%100.00%100.00%100.00%
EBIT Margin
924.08%753.32%71.96%-98865.71%-1075325.00%
EBITDA Margin
924.08%753.32%71.96%-575017.14%-8932150.00%
Operating Profit Margin
924.92%763.99%75.61%-85508.57%-965525.00%
Pretax Profit Margin
924.08%752.75%68.04%-590080.00%-8943775.00%
Net Profit Margin
924.03%752.66%67.99%-590305.71%-8945300.00%
Continuous Operations Profit Margin
924.03%752.66%67.99%-590305.71%-8945300.00%
Net Income Per EBT
99.99%99.99%99.93%100.04%100.02%
EBT Per EBIT
99.91%98.53%89.99%690.08%926.31%
Return on Assets (ROA)
43.66%20.75%3.15%-7.83%-11.72%
Return on Equity (ROE)
49.95%20.81%3.32%-8.89%-13.32%
Return on Capital Employed (ROCE)
43.71%21.07%3.69%-1.14%-1.44%
Return on Invested Capital (ROIC)
43.70%21.06%3.51%-0.54%-1.27%
Return on Tangible Assets
43.66%20.75%3.15%-7.83%-11.72%
Earnings Yield
46.33%23.45%3.90%-8.82%-11.78%
Efficiency Ratios
Receivables Turnover
 11.04 13.93 0.00 0.02 0.00
Payables Turnover
 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.05 0.03 0.05 <0.01 <0.01
Working Capital Turnover Ratio
 0.08 0.06 0.05 <0.01 >-0.01
Cash Conversion Cycle
 33.05 26.20 0.00 19.07K 0.00
Days of Sales Outstanding
 33.05 26.20 0.00 19.07K 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 0.00
Operating Cycle
 33.05 26.20 0.00 19.07K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 5.49 5.64 5.54 3.98 -6.50
Free Cash Flow Per Share
 5.49 5.64 5.54 3.98 -6.50
CapEx Per Share
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 2.44 3.14 2.78 1.40 -1.69
Capital Expenditure Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 0.00 0.00 2.59 0.72 -0.99
Operating Cash Flow to Sales Ratio
 2.07 4.02 2.73 6.24K -89.45K
Free Cash Flow Yield
10.40%12.54%15.64%9.32%-11.78%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 2.16 4.26 25.65 -11.34 -8.49
Price-to-Sales (P/S) Ratio
 19.94 32.10 17.44 66.94K 759.15K
Price-to-Book (P/B) Ratio
 0.94 0.89 0.85 1.01 1.13
Price-to-Free Cash Flow (P/FCF) Ratio
 9.62 7.97 6.39 10.73 -8.49
Price-to-Operating Cash Flow Ratio
 9.62 7.97 6.39 10.73 -8.49
Price-to-Earnings Growth (PEG) Ratio
 <0.01 <0.01 -0.19 0.27 0.77
Price-to-Fair Value
 0.94 0.89 0.85 1.01 1.13
Enterprise Value Multiple
 2.01 4.09 25.69 -13.15 -9.51
Enterprise Value
 2.71B 2.37B 2.06B 2.65B 3.40B
EV to EBITDA
 2.01 4.09 25.69 -13.15 -9.51
EV to Sales
 18.55 30.82 18.49 75.64K 849.41K
EV to Free Cash Flow
 8.94 7.66 6.78 12.13 -9.50
EV to Operating Cash Flow
 8.94 7.66 6.78 12.13 -9.50
Tangible Book Value Per Share
 55.93 50.67 41.57 42.39 48.83
Shareholders’ Equity Per Share
 55.93 50.67 41.57 42.39 48.83
Tax and Other Ratios
Effective Tax Rate
 <0.01 <0.01 <0.01 >-0.01 >-0.01
Revenue Per Share
 2.65 1.40 2.03 <0.01 <0.01
Net Income Per Share
 24.46 10.54 1.38 -3.77 -6.50
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.00 1.00 0.95 5.97 8.32
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.05 0.00 0.24 120.77 1.03K
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.22 0.00 0.00 -1.06 1.00
Currency in CHF